Mood disorders in elderly population: Neurostimulative treatment possibilities

Recent Patents on CNS Drug Discovery

Volumn 4, Issue 2, 2009, Pages 149-155

  Rosenberg, Oded ^a   Shoenfeld, Netta ^a   Kotler, Moshe ^a   Dannon, Pinhas N ^a  

^a BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

Author keywords

Affective disorders; DBS; Depression; ECT; Elderly; Mood disorders; TMS; VNS

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

AGED; BIPOLAR DEPRESSION; BIPOLAR MANIA; BRAIN DEPTH STIMULATION; DEPRESSION; DEPRESSIVE PSYCHOSIS; DRUG MECHANISM; ELDERLY CARE; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION THERAPY; HUMAN; MAJOR DEPRESSION; MANIA; MOOD DISORDER; NERVE STIMULATION; PARKINSON DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT INDICATION; VAGUS NERVE STIMULATION; AGING; BIBLIOGRAPHIC DATABASE; DOUBLE BLIND PROCEDURE; GERIATRICS; METHODOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

AGING; ANTIDEPRESSIVE AGENTS; DATABASES, BIBLIOGRAPHIC; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; GERIATRICS; HUMANS; MOOD DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 68849085664     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488909788453013     Document Type: Review

References (58)

1. Cole MG, Dendukuri N. Factors for depression among elderly community subjects: A systematic review and meta-analysis. Am J Psychiatry 2003; 160(6): 1147-1156.
2. Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: A systematic review and meta-analysis. Am J Psychiatry 1999; 156(8): 1182-1189.
3. Meyer, J.H., Ginovart, N.: WO2007014467 (2007).
4. Cohen, B.M., Murphy, B.L.: WO2008066916 (2008).
5. Aziz R, Lorberg B and Tampi RR. Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother 2006; 4: 347-364.
6. Jorge RE, Moser DJ, Acion L, et al. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008; 65: 268-276.
7. Alastair JF. Pharmacologic treatment of depression in late life. Can Med Assoc J 1997; 15: 209-217.
8. Flint AJ. Pharmacologic treatment of depression in late life. Can Med Assoc J 1997; 157: 1061-1067.
9. Tew JD Jr, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the Old-Old. Am J Psychiatry 1999; 156: 1865-1870.
10. van der Wurff FB, Stek ML, Hoogendijk WJG, et al. The efficacy and safety of ECT in depressed older adults, a literature review. Int J Geriatr Psychiatry 2003; 18: 894-904.
11. Tew JD Jr, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999; 156: 12.
12. Little JD, Atkins MR, Munday J et al. Bifrontal electroconvulsive therapy in the elderly: A 2-year retrospective. J ECT 2004; 20: 139-141.
13. Finlay-Jones R, Parker G. M.A consensus conference on psychotic depression. Aust N Z J Psychiatry 1993; 27: 581-589.
14. Alastair JF, Sandra R. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT Int j Geriat Psychiatry 1998; 13: 23-28.
15. Benbow M. The role of electroconvulsive therapy in the treatment of depressive illness in old ages. British J of Psychiatry 1989; 155, 147-152.
16. Tielkes CE, Comijs HC, Verwijk E, et al. The effects of ECT on cognitive functioning in the elderly: A review. Int J Geriatr Psychiatry 2008; 23: 789-795.
17. Barker AT. The history and basic principles of magnetic nerve stimulation. In: Pascual-Leone, A., Davey, N., RothwellJ., Wassermann, E.M., Puri, B.K. (Eds.), Handbook of Transcranial Magnetic Stimulation, 1st ed. Oxford Univ Press, New York, 2002, pp. 3-17.
18. Roth Y, Amir A, Levkovitz Y et al. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 2007; 24: 31-38.
19. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 2005; 88: 255-267.
20. Squire LR, Slater PC, Miller PL. Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up. Arch Gen Psychiatry. 1981 ;38:89-95.
21. George MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995; 6: 1853-1856.
22. Figiel GS, Epstein C, McDonald WM, et al. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. Neuropsychiatry Clin Neurosci 1998; 10: 20-25.
23. Triggs WJ, McCoy KJ, Greer R et al. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry 1999; 45: 1440-1446.
24. Pascual-Leone A, Rubio B, Pallardo F, et al. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348: 233-237.
25. George MS, Wasserman EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: A placebo-controlled crossover trial. Am J Psychiatry 1997; 154: 1752-1756.
26. Eschweiler GW, Wegerer C, Schlotter W, et al. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res 2000; 99: 161-172.
27. García-Toro M, Mayol A, Arnillas H, et al. Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Disord 2001; 64: 271-275.
28. Berman RM, Narasimhan M, Sanacora G, et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 2000; 47: 332-337.
29. Klein E, Kreinin I, Chistyakov A, et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: A double-blind controlled study. Arch Gen Psychiatry 1999; 56: 315-320.
30. Dannon PN, Lowengrub K, Gonopolski Y, et al. Current and emerging somatic treatment strategies in psychotic major depression. Expert Rev Neurotherapeutics 2006; 6: 73-80.
31. Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003; 53:324-331.
32. Galinowski FA, Oppenheim C, Gallarda T, et al. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: An open trial. Int J Geriatr Psychiatry 2004; 19: 833-842.
33. Nahas Z, Kozel FA, Li X, et al. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: A pilot study of acute safety and efficacy. Bipolar Disord 2003; 5: 40-47.
34. Michael N, Erfurth A. Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. J Affect Disord 2004; 78: 253-257.
35. Grisaru N, Chudakov B, Yaroslavsky D, et al. Transcranial magnetic stimulation in mania: A controlled study. Am J Psychiatry 1998; 155: 1608-1610.
36. Wassermann EM. Risk and safety of 30 repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalography and Clinical Neurophysiology 1998; 108: 1-16.
37. Janicak PG, o'Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: A comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.J Clin Psychiatry 2008; 69: 222-232.
38. Patel AR, Wozniak SM. Improved mood and remission of symptoms in long-term major depression using vagus nerve stimulation. MedGenMed 2007; 9: 62.
39. Zwanzger P, Ella R, Keck ME, et al. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 2002; 51: 602-603.
40. Labiner DM, Ahern GL. Vagus nerve stimulation therapy in depression and epilepsy: Therapeutic parameter settings. Acta Neurol Scand 2007; 115: 23-33.
41. Carpenter LL, Friehs GM, Price LH. Cervical vagus nerve stimulation for treatment-resistant depression. Neurosurg Clin N Am 2003; 14: 275-282.
42. Schlaepfer TE, Frick C, Zobel A, et al. Vagus nerve stimulation for depression: Efficacy and safety in a European study. Psychol Med 2008; 38: 651-661.
43. Shuchman M. Approving the vagus-nerve stimulator for depression. N England J Med 2007; 356: 1604-1607.
44. Corcoran CD, Thomas P, Phillips J, et al. Vagus nerve stimulation in chronic treatment-resistant depression: Preliminary findings of an open-label study. Br J Psychiatry 2006; 189: 282-283.
45. Marangell LB, Suppes T, Zboyan HA, et al. A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. J Clin Psychiatry 2008; 69: 183-189.
46. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biol Psychiatry 2005; 58: 347-354.
47. Lisanby SH, Luber B, Schlaepfer TE, et al. Safety and feasibility of magnetic seizure therapy (MST) in major depression: Randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28: 1852-1865.
48. Lisanby SH. Update on magnetic seizure therapy: A novel form of convulsive therapy. J of ECT 2002; 18: 182-188.
49. Schlaepfer TE, Cohen MX, Frick C, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008; 33: 368.
50. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-660.
51. Tröster AI, Fields JA, Wilkinson S, et al. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 2003; 80: 43-47.
52. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in parkinson's disease's 2004; 75: 834-839.
53. Castelli L, Perozzo P, Zibetti M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: Effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006; 55(3): 136-144.
54. Philip A, Chadwick W. Christine W, et al. Implantation of deep brain stimulators into the subthalamicnucleus: technical approach and magnetic resonance imaging verified lead locations. J Neurosurg 2002; 97: 370-387.
55. Grill WM. Safety considerations for deep brain stimulation: Review and analysis. Expert 2005; 2: 409-420.
56. Sansur CA, Frysinger RC, Pouratian N, et al. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg 2007; 107: 998-1003.
57. Been G, Ngo TT, Miller SM, et al. The use of tDCS and CVS as methods of non-invasive brain stimulation. Brain Res Rev 2007; 56: 346-361.
58. Boggio PS, Rigonatti SP, Ribeiro RB, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008; 11: 249-254.